StockNews.AI
PGNY
StockNews.AI
187 days

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report

1. Progyny will report Q4 and full-year results on February 27, 2025. 2. A conference call after results will provide insights into financial performance. 3. Progyny is recognized for its innovation and growth by various media outlets. 4. The company aims to improve patient outcomes and reduce healthcare costs.

4m saved
Insight
Article

FAQ

Why Neutral?

While earnings could affect PGNY's stock positively or negatively, no drastic changes are indicated.

How important is it?

Upcoming earnings are critical for PGNY; investors will closely watch performance metrics.

Why Short Term?

The immediate focus is on upcoming financial results, impacting investor sentiment shortly.

Related Companies

VRTXALNYCNC
February 13, 2025 15:14 ET  | Source: Progyny, Inc. NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period and full year ended December 31, 2024, after the close of the market on Thursday, February 27, 2025. The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode. An audio replay of the call will be available through Tuesday, March 6, 2025, and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484. A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com. About Progyny Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians. Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs. Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com. For Further Information, Please Contact:Investors:James Hartinvestors@progyny.com Media:Alexis Fordmedia@progyny.com

Related News